KRIBIOLISA™ Blinatumomab ELISA (BLINCYTO™)
KRISHGEN BioSystemsELISA for the detection of Blinatumomab in human serum and plasma. Lead time for this kit is 5 weeks.
About the kit:
- Uses anti-idiotypic monoclonal antibodies sourced from our vendor partner in the US, which ensures higher specificity, and low cross reactivity.
- Recovery rates are between 85 - 115%
- Validated as per US FDA guidelines for Bioassays
- Developed using the innovator drug as calibrator
- Shelf life: 1 year